Literature DB >> 23660166

Successful management of evisceration occurred after exploratory laparotomy for bilateral ovarian micropapillary serous borderline tumors.

C Grigoriadis1, A Vezakis, N Salakos, O Triantafyllidou, N F Vlahos.   

Abstract

Micropapillary serous borderline tumor of the ovary is characterized by a more frequent association with extraovarian, especially invasive, implants. The aim of this study was to report the clinicopathological findings of a rare case of micropapillary serous borderline tumor of the ovary since there are less than 100 similar cases in the published literature. Additionally, the successful management of evisceration that complicated the postoperative stay of the patient is analyzed. The incidence of this severe complication is estimated between 0.29-2.3%. There are four main causes: suture tearing through the fascia, knot failure, suture failure, and extrusion of abdominal contents between sutures placed too far apart. At least 50% of the cases are due to technical error with a potentially lethal result.

Entities:  

Mesh:

Year:  2013        PMID: 23660166      PMCID: PMC3915579     

Source DB:  PubMed          Journal:  G Chir        ISSN: 0391-9005


  18 in total

1.  [Fascia dehiscence--cause and prognosis].

Authors:  W Wahl; H Menke; M Schnütgen; T Junginger
Journal:  Chirurg       Date:  1992-08       Impact factor: 0.955

2.  Burst abdomen--clinical features and factors influencing mortality.

Authors:  G Madsen; L Fischer; P Wara
Journal:  Dan Med Bull       Date:  1992-04

Review 3.  Acute wound failure.

Authors:  M A Carlson
Journal:  Surg Clin North Am       Date:  1997-06       Impact factor: 2.741

4.  Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases.

Authors:  J D Seidman; R J Kurman
Journal:  Am J Surg Pathol       Date:  1996-11       Impact factor: 6.394

5.  Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors.

Authors:  R T Burks; M E Sherman; R J Kurman
Journal:  Am J Surg Pathol       Date:  1996-11       Impact factor: 6.394

6.  Ovarian micropapillary serous borderline tumors. Clinicopathologic features and outcome of seven surgically staged patients.

Authors:  N S Goldstein; N Ceniza
Journal:  Am J Clin Pathol       Date:  2000-09       Impact factor: 2.493

7.  Prognostic factors for patients with advanced stage serous borderline tumours of the ovary.

Authors:  P Morice; S Camatte; A Rey; D Atallah; C Lhommé; P Pautier; C Pomel; J-F Coté; C Haie-Meder; P Duvillard; D Castaigne
Journal:  Ann Oncol       Date:  2003-04       Impact factor: 32.976

8.  Results after conservative treatment of serous borderline tumors of the ovary with a micropapillary pattern.

Authors:  Isabelle Laurent; Catherine Uzan; Sebastien Gouy; Patricia Pautier; Pierre Duvillard; Philippe Morice
Journal:  Ann Surg Oncol       Date:  2008-09-27       Impact factor: 5.344

9.  Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization.

Authors:  Chunliu Zhan; Marlene R Miller
Journal:  JAMA       Date:  2003-10-08       Impact factor: 56.272

10.  Micropapillary and cribriform patterns in ovarian serous tumors of low malignant potential: a study of 99 advanced stage cases.

Authors:  Michael T Deavers; David M Gershenson; Guillermo Tortolero-Luna; Anais Malpica; Karen H Lu; Elvio G Silva
Journal:  Am J Surg Pathol       Date:  2002-09       Impact factor: 6.394

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.